The Globe and Mail reports in its Thursday, Oct. 30, edition that ATB Capital Markets analyst Chris Murray, ahead of the release of Atkinsrealis Group's third quarter results on Nov. 13, raised his share target to $118 from $115 with an unchanged "outperform" ranking. The Globe's David Leeder writes in the Eye On Equities column that analysts on average target the shares at $112.77. Mr. Murray says in a note: "We are revising our margin expectations for H2/25 to account for seasonality on a regional basis in engineering services (ES) and the growth/margin outlook in nuclear, with full-year estimates remaining in line with management's outlook. Our revised adjusted EBITDA estimate for Q3/25 of $283-million is slightly above consensus and is underpinned by mid-single-digit organic growth and margin expansion in ES combined, strong top-line growth in nuclear and its first full quarter contribution from recently acquired David Evans. We expect capital allocation, particularly the M&A opportunity set and potential buyback activity, to be a focus with the quarter, as the company is in a net cash position following the sale of its 407 stake. While it has outperformed in 2025, we would remain buyers."